CARLSBAD, Calif., Oct. 9 /PRNewswire/ -- SkinMedica, Inc. announced today
an agreement with La Jolla based Advanced Tissue Sciences, Inc. (Nasdaq: ATIS)
to evaluate the potential of Advanced Tissue Sciences' nutrient solution in
cosmeceutical applications. The nutrient solution is created by the secretion
of cytokines, collagen and other nutrients during Advanced Tissue Sciences
proprietary tissue engineering manufacturing process. It is these elements
which are essential to youthful skin and are produced in lesser quantities as
an individual ages.
Under the agreement, SkinMedica, Inc. will conduct clinical evaluations of
products containing the nutrient solution and will provide clinical expertise
and consulting services to Advanced Tissue Sciences. SkinMedica, Inc.
received a license to certain Advanced Tissue Sciences' patents along with
exclusive worldwide rights to market skincare products containing the highest
concentrations of the nutrient solution to physicians and medical spas.
"We at SkinMedica, Inc. are excited about the possibility of bringing the
science and technology of Advanced Tissue Sciences to the cosmeceutical
marketplace," stated Richard E. Fitzpatrick, M.D., Chairman of SkinMedica's
Board of Directors and a nationally renown dermatologist and current President
of the American Society for Laser Medicine and Surgery. "The early
development work on these skincare products appears to demonstrate clinically
important results -- unlike anything seen before in the cosmeceutical market."
"Through this arrangement with SkinMedica, Inc., we will be exploring the
use of our patented process to replicate nature's method for rejuvenating
skin," stated Gail Naughton, Ph.D., President of Advanced Tissue Sciences and
recipient of the 2000 National Inventor of the Year Award by the prestigious
Intellectual Property Owners Association.
According to Thomas V. Compton, CEO of SkinMedica, Inc., "We have a
prestigious team of world renown dermatologists and plastic surgeons, who will
be participating in the evaluation of this exciting rejuvenative product.
This new product has the potential to be a revolutionary cosmeceutical for
diminishing the signs of aging and maintaining healthy skin."
SkinMedica, Inc. is a privately held cosmeceutical company founded in
1999 by practicing dermatologists, which focuses on a scientific approach to
skincare. Sales of its products have been growing at a rapid rate and are
being enthusiastically received by patients of dermatologists and plastic
surgeons who distribute these products through their medical practices.
Statements in this press release that are not strictly historical may be
"forward-looking" statements, which involve risks and uncertainties. Actual
results may differ from those described in this press release due to risks and
uncertainties. The Company undertakes no obligation to release publicly the
results of any revision to these forward-looking statements to reflect events
or circumstances arising after the date hereof.
For additional information, please contact Thomas V. Compton at
(877) 944-1412.
SOURCE SkinMedica, Inc.
 back to top
Company News On-Call:
http://www.prnewswire.com/comp/532975.html or fax,
800-758-5804, ext. 532975
CONTACT:
Thomas V. Compton of SkinMedica, Inc.,
877-944-1412
|
